Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :1300
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


Nilotinib as first-line therapy for chronic myeloid leukemia

Vaid A

Year : 2011| Volume: 48| Issue : 4 | Page no: 438-445

   This article has been cited by
1 Amyloid -induced elevation of O-GlcNAcylated c-Fos promotes neuronal cell death
Heesun Choi,Chaeyoung Kim,Hyundong Song,Moon-Yong Cha,Hyun Jin Cho,Sung Min Son,Haeng Jun Kim,Inhee Mook-Jung
Aging Cell. 2019; 18(1): e12872
[Pubmed]  [Google Scholar] [DOI]
2 Comparative efficacy and safety of tyrosine kinase inhibitors for chronic myeloid leukaemia: A systematic review and network meta-analysis
Mariana M. Fachi,Fernanda S. Tonin,Leticia P. Leonart,Karina S. Aguiar,Luana Lenzi,Bonald C. Figueiredo,Fernando Fernandez-Llimos,Roberto Pontarolo
European Journal of Cancer. 2018; 104: 9
[Pubmed]  [Google Scholar] [DOI]
3 Management of gastrointestinal stromal tumor: The lmatinib era and beyond
Parikh, P.M. and Gupta, S.
Indian Journal of Cancer. 2013; 50(1): 31-40
[Pubmed]  [Google Scholar]
4 Optimizing second-line therapy for chronic myeloid leukemia
Raja, T.
Indian Journal of Cancer. 2012; 49(1): 46-56
[Pubmed]  [Google Scholar]


  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow